Jacc asia文章索引

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry [0.03%] 韩国急性心肌梗死注册项目中钙通道阻滞剂与β受体阻滞剂临床疗效的差异分析

Moo Hyun Kim,Song Lin Yuan,Kwang Min Lee et al. Moo Hyun Kim et al.

Background: Although current guidelines recommend beta-blockers (BBs) after acute myocardial infarction (AMI), the role of calcium-channel blockers (CCBs) has not been well investigated, especially nondihydropyridine. ...

JACC. Asia. 2023 May 2;3(3):446-454. DOI:10.1016/j.jacasi.2023.02.006 2023

Timing of Myocardial Infarction Diagnosis in Type A Acute Aortic Dissection and Coronary Artery Involvement [0.03%] 急性A型主动脉夹层合并冠状动脉受累患者的心肌梗死诊断时间分析

Shinya Ichihara,Yuichi Saito,Osamu Hashimoto et al. Shinya Ichihara et al.

JACC. Asia. 2023 May 23;3(3):531-533. DOI:10.1016/j.jacasi.2023.03.012 2023

The Increasing Prevalence of Metabolic Syndrome in Korea: A Multifarious Disease With a Multifactorial Etiology [0.03%] 韩国代谢综合征的流行率增加：一种病因多样化的疾病

Andrea J Lobene Andrea J Lobene

Editorial JACC. Asia. 2023 Jun 20;3(3):503-505. DOI:10.1016/j.jacasi.2023.05.004 2023

A Big Call to Action: Improving STEMI Management in Low- and Middle-Income Countries [0.03%] 行动起来——提升低收入及中等收入国家STEMI的救治水平

Hyuck-Jun Yoon Hyuck-Jun Yoon

Editorial JACC. Asia. 2023 Jun 20;3(3):443-445. DOI:10.1016/j.jacasi.2023.05.005 2023

Growth Differentiation Factor-15 and Clinical Outcomes in Japanese Patients With Ischemic Heart Disease [0.03%] 生长分化因子-15与缺血性心脏病患者的临床预后之间的关系研究（日本人群）

Yuta Kobayashi,Yoichiro Otaki,Tetsu Watanabe et al. Yuta Kobayashi et al.

Background: Despite a reduction in the rate of thrombotic events, ischemic heart disease (IHD) remains a key medical problem associated with high major bleeding and mortality in Asian patients with IHD. Growth differentia...

JACC. Asia. 2023 May 9;3(3):457-471. DOI:10.1016/j.jacasi.2023.03.008 2023

Call for Submissions on Basic and Translational Sciences [0.03%] 征稿：基础和转化医学研究

Yibin Wang Yibin Wang

Editorial JACC. Asia. 2023 Jun 13;3(3):536-537. DOI:10.1016/j.jacasi.2023.05.003 2023

Renal Function and Clinical Outcomes Among Elderly Patients With Nonvalvular Atrial Fibrillation From ANAFIE [0.03%] 来自ANAFIE的老年人非瓣膜性房颤患者的肾功能与临床结局

Wataru Shimizu,Takeshi Yamashita,Masaharu Akao et al. Wataru Shimizu et al.

Background: Advancing age, decreasing renal function, and atrial fibrillation are strongly associated. Real-world evidence of direct oral anticoagulant (DOAC) use among elderly patients ≥75 years of age with nonvalvular ...

JACC. Asia. 2023 Apr 11;3(3):475-487. DOI:10.1016/j.jacasi.2023.02.002 2023

Diagnosing HFpEF and Predicting ESLD Liver Transplant Outcome Using HFA-PEFF Score [0.03%] 使用HFA-PEFF评分诊断HFpEF和预测ESLD肝移植预后

Xiuhong Lyu Xiuhong Lyu

Editorial JACC. Asia. 2023 Jun 20;3(3):518-520. DOI:10.1016/j.jacasi.2023.04.005 2023

Reply: Underutilization of Fibrinolysis Despite Timely Arrival in STEMI: A Missed Opportunity! [0.03%] 答复：STEMI患者及时到达后未充分利用溶栓疗法：一个被错过的机遇！

Kirtipal Bhatia,Arman Qamar,Michael Hendrickson et al. Kirtipal Bhatia et al.

JACC. Asia. 2023 Jun 20;3(3):535. DOI:10.1016/j.jacasi.2023.05.006 2023

Primary Prevention of Sudden Cardiac Death in Asia [0.03%] 亚洲突发性心脏死亡的一级预防措施

Chu-Pak Lau,Hung-Fat Tse Chu-Pak Lau

Editorial JACC. Asia. 2023 Jun 6;3(3):346-348. DOI:10.1016/j.jacasi.2023.04.006 2023